|
|
 |
|
Viewing report
|
|
|
|
Global Drug Manufacturing Industry Outlook to 2010: Buyer Spend and Procurement Strategies and the Impact of Recession and Recovery
iCD Research, July 2009, Pages: 111
“Global Drug Manufacturing Industry Outlook to 2010” analyzes how drug manufacturing companies products & services spend, procurement strategies & practices and business are being affected by the recession. In an uncertain economic climate this report gives you access to the category-level spending outlooks, buyer budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also identifies buyers and suppliers future growth, M&A and investment expectations. The research is based on an extensive survey of senior and C-level industry executives from our market leading panels.
Scope
- The opinions and forward looking statements of over 550 industry executives have been captured in our in-depth survey, of which 65% represent Directors, C-levels & Departmental Heads
- This report covers data and analysis on buyer spend, procurement and industry developments by pharmaceutical process and manufacturing, biopharma, biotech, public sector pharma, CRO and CMO companies and leading suppliers worldwide
- The report examines current practices and provides future expectations over the next 12-24 months
- The research is based on primary survey research conducted by Global Markets Direct in association with ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations
- Key topics covered include buyer spend activity, procurement behaviors & strategies and how these have been affected by the recession, threats & opportunities for the drug manufacturing industry, economic outlook and business confidence.
- In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats
- The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results
- The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East
Highlights
- 40% of drug manufacturers expect to increase their procurement spend over the next 12 months, a further 22% looking to maintain it at current levels, however with many claiming to be re-evaluating their supplier base the market open to competition is expected to increase over the coming year
- 38% of buyers are seeking to engage in partnerships to optimize working capital and reduce costs - closer cooperation between suppliers and buyers is being sought during this time of market uncertainty
- Only 14% of drug manufacturers do not regularly evaluate suppliers to ensure they meet high ethical and environmental standards
Reasons to buy
- Drive revenues by understanding future product investment areas and growth regions by leading industry players
- Formulate effective sales & marketing strategies by identifying how buyer budgets are changing and where spend will be directed to in the future
- Better promote your business by aligning your capabilities and business practices with your customer’s changing needs during these times of market uncertainty
- Secure stronger customer relationships by understanding the leading business concerns and changing strategies of buyers in the pharmaceutical industry
- Effectively plan your business strategies
- Predict how the industry will grow, consolidate and where it will stagnate
- Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry
Customers who bought this item also bought
Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
Buyer Spend Activity and Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2011-2012: Survey Intelligence
Global Pharmaceutical Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Buyer Spend and Procurement Strategies
Global Pharmaceutical Supplier Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry
What The Global Pharmaceutical Industry Is Planning In 2010-2011: Procurement, Investment & Industry Trends Outlook
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
Industry Dynamics, Growth, Threats & Opportunities in the Pharmaceutical Industry - 2011-2012: Survey Intelligence
Procurement Behaviors and Strategies in the Pharmaceutical Industry - 2011-2012: Survey Brief
Threats and Opportunities in the Pharmaceutical Industry - 2011-2012: Survey Brief
|
|
|
|
